|
[1] GARCIA-TSAO G,FRIEDMAN S,IREDALE J,et al. Now there are many(stages)where before there was one:In search of a pathophysiological classification of cirrhosis[J].Hepatology,2010,51(4):1445-1449.
|
|
[2] RODRGUEZ-DAZ JL,ROSAS-CAMARGO V,VEGA-VEGA O,et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis:A long-term follow-up study[J]. Clin Oncol(R Coll Radiol),2007,19(3):197-203.
|
|
[3] KIM MY,CHO MY,BAIK SK,et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension[J].J Hepatol,2011,55(5):1004-1009.
|
|
[4] KIM G,LEE SS,BAIK SK,et al. The need for histological subclassification of cirrhosis:A systematic review and meta-analysis[J]. Liver Int,2016,36(6):847-855.
|
|
[5] WANG W,LI J,PAN R,et al. Association of the Laennec staging system with degree of cirrhosis,clinical stage and liver function[J]. Hepatol Int,2015,9(4):621-626.
|
|
[6] KIM SU,OH HJ,WANLESS IR,et al. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis[J].J Hepatol,2012,57(3),556-563.
|
|
[7] KIM SU,JUNG KS,LEE S,et al. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma[J]. Liver Int,2014,34(7):1008-1017.
|
|
[8] NAGULA S,JAIN D,GROSZMANN RJ,et al. Histologicalhemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis[J]. J Hepatol,2006,44(1):111-117.
|
|
[9] RIPOLL C,GROSZMANN RJ,GARCIA-TSAO G,et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis[J].J Hepatol,2009,50(5):923-928.
|
|
[10] RIPOLL C,GROSZMANN R,GARCIA-TSAO G,et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis[J]. Gastroenterology,2007,133(2):481-488.
|
|
[11] ROSKAMS T,BAPTISTA A,BIANCHI L,et al. Histopathology of portal hypertension:Apractical guideline[J]. Histopathology,2003,42(1):2-13.
|
|
[12] WU QM,ZHAO XY,YOU H. Quantitative fibrosis parameters highly predict esophageal-gastro varices in primary biliary cirrhosis[J]. Eur Rev Med Pharmacol Sci,2016,20(6):1037-1043.
|
|
[13] XU S,WANG Y,TAI DCS,et al. qFibrosis:A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J]. J Hepatol,2014,61(2):260-269.
|
|
[14] CALVARUSO V,BURROUGHS AK,STANDISH R,et al. Computer-assisted image analysis of liver collagen:Relationship to Ishak scoring and hepatic venous pressure gradient[J].Hepatology,2009,49(4):1236-1244.
|
|
[15] MANOUSOU P,DHILLON AP,ISGRO G,et al. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation[J]. Liver Transpl,2011,17(2):178-188.
|
|
[16] TSOCHATZIS E,BRUNO S,ISGRO G,et al. Col agen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis[J]. J Hepatol,2014,60(5):948-954.
|
|
[17] MANOUSOU P,BURROUGHS AK,TSOCHATZIS E,et al.Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation[J]. J Hepatol,2013,58(5):962-968.
|
|
[18] CO爦AR AM,YAKAR T,SERIN E,et al. The relationship between fibrosis and nodule structure and esophageal varices[J]. Turk J Gastroenterol,2019,30(7):624-629.
|
|
[19] van LEEUWEN DJ,HOWE SC,SCHEUER PJ,et al. Portal hypertension in chronic hepatitis:Relationship to morphological changes[J]. Gut,1990,31(3):339-343.
|
|
[20] COLMAN JC,BRITTON RS,ORREGO H,et al. Relation between osmotically induced hepatocyte enlargement and portal hypertension[J]. Am J Physiol,1983,245(3):g382-g387.
|
|
[21] BLENDIS LM,ORREGO H,CROSSLEY IR,et al. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease[J]. Hepatology,1982,2(5):539-546.
|
|
[22] DONATO MF,AROSIO E,DEL NINNO E,et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity[J]. Hepatology,2001,34(3):523-528.
|
|
[23] ZHOU P,XIA J,ZHOU YJ,et al. Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients[J]. World J Gastroenterol,2015,21(21):6665-6674.
|
|
[24] SUN Y,ZHOU J,WANG L,et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology,2017,65(5):1438-1450.
|
|
[25] LEE HW,NA K,KIM SU,et al. Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy[J]. Sci Rep,2019,9(1):15628.
|
|
[26] BEDOSSA P. Reversibility of hepatitis B virus cirrhosis after therapy:Who and why?[J]. Liver Int,2015,35(Suppl 1):78-81.
|
|
[27] FLEMING KE,WANLESS IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis[J]. Liver Int,2013,33(4):525-534.
|
DownLoad: